TRVI · Trevi Therapeutics, Inc.
Market Cap
$2.39B
Shares
142.48M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-06 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-18 | Trevi Therapeutics: Data Highlights from Trevi’s ATS 2026 Presentations | Presentation |
| 2026-05-13 | Bank of America Global Healthcare Conference 2026 | Conference |
| 2026-05-07 | Trevi Therapeutics, Inc – Investor and Analyst Day | Presentation |
| 2026-05-05 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-17 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-11 | Leerink Partners 2026 Global Healthcare Conference | Conference |
| 2025-11-13 | Trevi Therapeutics, Inc. - 3Q 2025 Financial Results | Event |
| 2025-09-10 | Morgan Stanley 23rd Annual Global Healthcare Conference | Conference |
| 2025-08-07 | Trevi Therapeutics, Inc. - 2Q 2025 Financial Results | Event |
| 2025-06-02 | Phase 2b CORAL Trial - Topline Results Webcast | Earnings call |
Key facts
CIK
1563880
CUSIP
89532M101
13F (30d)
190 filings
187 filers
Visit website
Investor relations